nodes	percent_of_prediction	percent_of_DWPC	metapath
Ingenol Mebutate—PRKCA—cerebellar cortex—brain cancer	0.0721	0.188	CbGeAlD
Ingenol Mebutate—PRKCA—telencephalic ventricle—brain cancer	0.042	0.109	CbGeAlD
Ingenol Mebutate—PRKCA—ganglion—brain cancer	0.0261	0.068	CbGeAlD
Ingenol Mebutate—PRKCA—endothelium—brain cancer	0.0225	0.0586	CbGeAlD
Ingenol Mebutate—PRKCA—blood vessel—brain cancer	0.0208	0.054	CbGeAlD
Ingenol Mebutate—PRKCA—hindbrain—brain cancer	0.0198	0.0515	CbGeAlD
Ingenol Mebutate—PRKCD—telencephalon—brain cancer	0.0183	0.0476	CbGeAlD
Ingenol Mebutate—PRKCD—gonad—brain cancer	0.0153	0.0397	CbGeAlD
Ingenol Mebutate—PRKCD—pituitary gland—brain cancer	0.0149	0.0387	CbGeAlD
Ingenol Mebutate—PRKCD—endocrine gland—brain cancer	0.0115	0.03	CbGeAlD
Ingenol Mebutate—PRKCD—head—brain cancer	0.0114	0.0296	CbGeAlD
Ingenol Mebutate—PRKCA—brainstem—brain cancer	0.0114	0.0295	CbGeAlD
Ingenol Mebutate—PRKCD—central nervous system—brain cancer	0.0104	0.027	CbGeAlD
Ingenol Mebutate—PRKCD—cerebellum—brain cancer	0.0102	0.0264	CbGeAlD
Ingenol Mebutate—PRKCA—telencephalon—brain cancer	0.0101	0.0262	CbGeAlD
Ingenol Mebutate—PRKCA—gonad—brain cancer	0.00841	0.0219	CbGeAlD
Ingenol Mebutate—PRKCD—brain—brain cancer	0.00825	0.0215	CbGeAlD
Ingenol Mebutate—PRKCA—pituitary gland—brain cancer	0.0082	0.0213	CbGeAlD
Ingenol Mebutate—PRKCA—midbrain—brain cancer	0.00724	0.0188	CbGeAlD
Ingenol Mebutate—PRKCA—spinal cord—brain cancer	0.00706	0.0184	CbGeAlD
Ingenol Mebutate—PRKCA—endocrine gland—brain cancer	0.00636	0.0165	CbGeAlD
Ingenol Mebutate—PRKCA—head—brain cancer	0.00627	0.0163	CbGeAlD
Ingenol Mebutate—PRKCA—central nervous system—brain cancer	0.00573	0.0149	CbGeAlD
Ingenol Mebutate—PRKCA—cerebellum—brain cancer	0.0056	0.0146	CbGeAlD
Ingenol Mebutate—PRKCA—brain—brain cancer	0.00455	0.0118	CbGeAlD
Ingenol Mebutate—PRKCA—Disease—HES5—brain cancer	0.000478	0.000777	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Wnt Signaling Pathway and Pluripotency—MYC—brain cancer	0.000478	0.000776	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Cytokine Signaling in Immune system—IL2—brain cancer	0.000474	0.00077	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling Pathways—ABR—brain cancer	0.000473	0.000768	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by VEGF—VEGFA—brain cancer	0.000472	0.000766	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Cell Cycle—SKP2—brain cancer	0.00047	0.000764	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Cell Cycle, Mitotic—CDK6—brain cancer	0.000469	0.000761	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Downstream signal transduction—ERBB2—brain cancer	0.000468	0.00076	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Platelet activation, signaling and aggregation—PIK3CG—brain cancer	0.000468	0.00076	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways in Glioblastoma—TP53—brain cancer	0.000467	0.000759	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by FGFR—ERBB2—brain cancer	0.000466	0.000756	CbGpPWpGaD
Ingenol Mebutate—PRKCA—EGF/EGFR Signaling Pathway—ERBB2—brain cancer	0.000466	0.000756	CbGpPWpGaD
Ingenol Mebutate—PRKCD—NGF signalling via TRKA from the plasma membrane—EGFR—brain cancer	0.000464	0.000753	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by ERBB2—ERBB2—brain cancer	0.000463	0.000753	CbGpPWpGaD
Ingenol Mebutate—PRKCA—DAP12 signaling—ERBB2—brain cancer	0.000461	0.000749	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by GPCR—ABR—brain cancer	0.00046	0.000746	CbGpPWpGaD
Ingenol Mebutate—PRKCD—MAPK Signaling Pathway—TP53—brain cancer	0.000458	0.000744	CbGpPWpGaD
Ingenol Mebutate—PRKCA—ErbB1 downstream signaling—EGFR—brain cancer	0.000457	0.000742	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—DTX2—brain cancer	0.000456	0.000741	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling Pathways—GLI2—brain cancer	0.000456	0.000741	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Immune System—SKP2—brain cancer	0.000455	0.000739	CbGpPWpGaD
Ingenol Mebutate—PRKCA—beta-catenin independent WNT signaling—CTNNB1—brain cancer	0.00045	0.000731	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—brain cancer	0.000448	0.000728	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Disease—SHH—brain cancer	0.000443	0.00072	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Disease—ENO2—brain cancer	0.000443	0.00072	CbGpPWpGaD
Ingenol Mebutate—PRKCA—PDGFR-beta signaling pathway—STAT3—brain cancer	0.000437	0.00071	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by FGFR in disease—ERBB2—brain cancer	0.000434	0.000705	CbGpPWpGaD
Ingenol Mebutate—PRKCA—DAP12 interactions—ERBB2—brain cancer	0.000434	0.000705	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by NGF—IRS2—brain cancer	0.000431	0.0007	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by EGFR—ERBB2—brain cancer	0.00043	0.000698	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling Pathways—GLI1—brain cancer	0.000429	0.000697	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Innate Immune System—IRS2—brain cancer	0.000428	0.000695	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by EGFR in Cancer—ERBB2—brain cancer	0.000426	0.000692	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Gene Expression—DNMT1—brain cancer	0.000425	0.000691	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Spinal Cord Injury—MYC—brain cancer	0.000425	0.000691	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by PDGF—ERBB2—brain cancer	0.000424	0.000689	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Hemostasis—PIK3CG—brain cancer	0.00042	0.000682	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Cell Cycle—CDK6—brain cancer	0.000419	0.000681	CbGpPWpGaD
Ingenol Mebutate—PRKCD—GPCR downstream signaling—VAV1—brain cancer	0.000418	0.000679	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Spinal Cord Injury—EGFR—brain cancer	0.000416	0.000676	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Integrated Pancreatic Cancer Pathway—ERBB2—brain cancer	0.000408	0.000663	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling Pathways—SUFU—brain cancer	0.000407	0.000661	CbGpPWpGaD
Ingenol Mebutate—PRKCA—PDGFR-beta signaling pathway—MYC—brain cancer	0.000406	0.00066	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Cytokine Signaling in Immune system—STAT3—brain cancer	0.000399	0.000648	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by SCF-KIT—STAT3—brain cancer	0.000397	0.000645	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling Pathways—GFAP—brain cancer	0.000393	0.000638	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling by NGF—STAT3—brain cancer	0.000392	0.000637	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Wnt Signaling Pathway and Pluripotency—TP53—brain cancer	0.000392	0.000637	CbGpPWpGaD
Ingenol Mebutate—PRKCA—NGF signalling via TRKA from the plasma membrane—ERBB2—brain cancer	0.000384	0.000624	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Gene Expression—ESR2—brain cancer	0.000382	0.00062	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Hemostasis—VAV1—brain cancer	0.00038	0.000617	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling by GPCR—VAV1—brain cancer	0.000379	0.000616	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling Pathways—HEY1—brain cancer	0.000372	0.000604	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Metabolism—CYP2C9—brain cancer	0.000369	0.000599	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling Pathways—DLL1—brain cancer	0.000365	0.000593	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Gene Expression—NOTCH2—brain cancer	0.000362	0.000587	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by SCF-KIT—EGFR—brain cancer	0.000361	0.000586	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Integrated Pancreatic Cancer Pathway—CCND1—brain cancer	0.000361	0.000586	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Integrated Pancreatic Cancer Pathway—CTNNB1—brain cancer	0.000357	0.00058	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Downstream signal transduction—STAT3—brain cancer	0.000357	0.00058	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling by NGF—EGFR—brain cancer	0.000357	0.000579	CbGpPWpGaD
Ingenol Mebutate—PRKCA—EGF/EGFR Signaling Pathway—STAT3—brain cancer	0.000355	0.000577	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Cell Cycle, Mitotic—CCNE1—brain cancer	0.000353	0.000573	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by Wnt—APC—brain cancer	0.000351	0.000569	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Spinal Cord Injury—TP53—brain cancer	0.000349	0.000567	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Immune System—VAV1—brain cancer	0.000347	0.000563	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—PTCH2—brain cancer	0.000346	0.000562	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Downstream signaling of activated FGFR—EGFR—brain cancer	0.000345	0.000561	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Innate Immune System—VAV1—brain cancer	0.000342	0.000555	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—HES5—brain cancer	0.000335	0.000544	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by FGFR in disease—STAT3—brain cancer	0.000331	0.000537	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Platelet activation, signaling and aggregation—IL2—brain cancer	0.000329	0.000535	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Cell Cycle—BRCA2—brain cancer	0.000326	0.000529	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—STRADA—brain cancer	0.000325	0.000528	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Downstream signal transduction—EGFR—brain cancer	0.000324	0.000527	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by PDGF—STAT3—brain cancer	0.000324	0.000526	CbGpPWpGaD
Ingenol Mebutate—PRKCA—EGF/EGFR Signaling Pathway—EGFR—brain cancer	0.000323	0.000524	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by FGFR—EGFR—brain cancer	0.000323	0.000524	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Disease—IDH1—brain cancer	0.000322	0.000523	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by ERBB2—EGFR—brain cancer	0.000321	0.000522	CbGpPWpGaD
Ingenol Mebutate—PRKCA—GPCR downstream signaling—TRPC6—brain cancer	0.00032	0.00052	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Disease—VAV1—brain cancer	0.00032	0.00052	CbGpPWpGaD
Ingenol Mebutate—PRKCA—DAP12 signaling—EGFR—brain cancer	0.00032	0.000519	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Cell Cycle—CCNE1—brain cancer	0.000316	0.000513	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Integrated Pancreatic Cancer Pathway—VEGFA—brain cancer	0.000314	0.000511	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Metabolism—BSG—brain cancer	0.000314	0.000509	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Cell Cycle, Mitotic—PCNA—brain cancer	0.000313	0.000508	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling Pathways—SHH—brain cancer	0.00031	0.000504	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Gene Expression—SIRT1—brain cancer	0.000308	0.000499	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Disease—HEY1—brain cancer	0.000305	0.000496	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by GPCR—SHH—brain cancer	0.000302	0.00049	CbGpPWpGaD
Ingenol Mebutate—PRKCA—DAP12 interactions—EGFR—brain cancer	0.000301	0.000488	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by FGFR in disease—EGFR—brain cancer	0.000301	0.000488	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Disease—DLL1—brain cancer	0.000299	0.000486	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling Pathways—TRPC6—brain cancer	0.000299	0.000486	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by EGFR—EGFR—brain cancer	0.000298	0.000484	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by NGF—RELA—brain cancer	0.000297	0.000483	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by NGF—ERBB2—brain cancer	0.000296	0.00048	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Hemostasis—IL2—brain cancer	0.000295	0.00048	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by EGFR in Cancer—EGFR—brain cancer	0.000295	0.00048	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Innate Immune System—RELA—brain cancer	0.000295	0.00048	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling Pathways—SMO—brain cancer	0.000294	0.000478	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling Pathways—PTCH1—brain cancer	0.000294	0.000478	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by PDGF—EGFR—brain cancer	0.000294	0.000478	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Innate Immune System—ERBB2—brain cancer	0.000293	0.000477	CbGpPWpGaD
Ingenol Mebutate—PRKCA—NGF signalling via TRKA from the plasma membrane—STAT3—brain cancer	0.000293	0.000476	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by GPCR—TRPC6—brain cancer	0.000291	0.000472	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Integrated Pancreatic Cancer Pathway—MYC—brain cancer	0.000289	0.00047	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by GPCR—SMO—brain cancer	0.000286	0.000464	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by GPCR—PTCH1—brain cancer	0.000286	0.000464	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Immune System—PDGFRA—brain cancer	0.000284	0.000461	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Integrated Pancreatic Cancer Pathway—EGFR—brain cancer	0.000283	0.00046	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Innate Immune System—PDGFRA—brain cancer	0.00028	0.000455	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Platelet activation, signaling and aggregation—VEGFA—brain cancer	0.00028	0.000454	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Cell Cycle—PCNA—brain cancer	0.00028	0.000454	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Disease—HES1—brain cancer	0.000275	0.000447	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—ABR—brain cancer	0.000271	0.000441	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Cell Cycle, Mitotic—CDK4—brain cancer	0.00027	0.000439	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Metabolism—IDH1—brain cancer	0.00027	0.000438	CbGpPWpGaD
Ingenol Mebutate—PRKCA—NGF signalling via TRKA from the plasma membrane—EGFR—brain cancer	0.000266	0.000433	CbGpPWpGaD
Ingenol Mebutate—PRKCD—GPCR downstream signaling—PIK3CG—brain cancer	0.000265	0.000431	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—GLI2—brain cancer	0.000262	0.000426	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Disease—PDGFRA—brain cancer	0.000262	0.000426	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Immune System—SKP2—brain cancer	0.000261	0.000424	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—brain cancer	0.000257	0.000418	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Innate Immune System—CTNNB1—brain cancer	0.000257	0.000417	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Disease—ENO2—brain cancer	0.000254	0.000413	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Disease—SHH—brain cancer	0.000254	0.000413	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Hemostasis—VEGFA—brain cancer	0.000251	0.000408	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Immune System—IRS2—brain cancer	0.000249	0.000405	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—GLI1—brain cancer	0.000246	0.0004	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Innate Immune System—IRS2—brain cancer	0.000246	0.000399	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Gene Expression—DNMT1—brain cancer	0.000244	0.000397	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Cell Cycle—CDK4—brain cancer	0.000242	0.000393	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Hemostasis—PIK3CG—brain cancer	0.000241	0.000392	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling by GPCR—PIK3CG—brain cancer	0.000241	0.000391	CbGpPWpGaD
Ingenol Mebutate—PRKCA—GPCR downstream signaling—VAV1—brain cancer	0.00024	0.00039	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by Wnt—CTNNB1—brain cancer	0.000238	0.000387	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Integrated Pancreatic Cancer Pathway—TP53—brain cancer	0.000238	0.000386	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling Pathways—NOTCH2—brain cancer	0.000235	0.000382	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—SUFU—brain cancer	0.000234	0.00038	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Disease—IRS2—brain cancer	0.00023	0.000374	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—GFAP—brain cancer	0.000225	0.000366	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by NGF—STAT3—brain cancer	0.000225	0.000366	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling Pathways—VAV1—brain cancer	0.000224	0.000364	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Gene Expression—ESR2—brain cancer	0.000219	0.000356	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by GPCR—VAV1—brain cancer	0.000218	0.000354	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—HEY1—brain cancer	0.000214	0.000347	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Metabolism—ENO2—brain cancer	0.000213	0.000346	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—DLL1—brain cancer	0.00021	0.00034	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Gene Expression—NOTCH2—brain cancer	0.000208	0.000337	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Cell Cycle, Mitotic—CDKN2A—brain cancer	0.000207	0.000336	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by NGF—EGFR—brain cancer	0.000205	0.000333	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Innate Immune System—EGFR—brain cancer	0.000203	0.00033	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Disease—APC—brain cancer	0.000203	0.00033	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Immune System—VAV1—brain cancer	0.000199	0.000323	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by Wnt—MYC—brain cancer	0.000193	0.000313	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling Pathways—HES1—brain cancer	0.000193	0.000313	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Hemostasis—TP53—brain cancer	0.00019	0.000308	CbGpPWpGaD
Ingenol Mebutate—PRKCD—GPCR downstream signaling—IL2—brain cancer	0.000187	0.000303	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Cell Cycle—CDKN2A—brain cancer	0.000185	0.0003	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Disease—VAV1—brain cancer	0.000184	0.000299	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling Pathways—PDGFRA—brain cancer	0.000184	0.000298	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—SHH—brain cancer	0.000178	0.000289	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling Pathways—SPP1—brain cancer	0.000178	0.000289	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Gene Expression—SIRT1—brain cancer	0.000177	0.000287	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Cell Cycle, Mitotic—CCND1—brain cancer	0.000175	0.000284	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Immune System—RELA—brain cancer	0.000172	0.000279	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—TRPC6—brain cancer	0.000172	0.000279	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Immune System—ERBB2—brain cancer	0.000171	0.000278	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Hemostasis—IL2—brain cancer	0.00017	0.000276	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Innate Immune System—RELA—brain cancer	0.00017	0.000276	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling by GPCR—IL2—brain cancer	0.00017	0.000275	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—PTCH1—brain cancer	0.000169	0.000274	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—SMO—brain cancer	0.000169	0.000274	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Innate Immune System—ERBB2—brain cancer	0.000169	0.000274	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Immune System—PDGFRA—brain cancer	0.000163	0.000265	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling Pathways—IRS2—brain cancer	0.000161	0.000262	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Disease—HES1—brain cancer	0.000158	0.000257	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Disease—ERBB2—brain cancer	0.000158	0.000256	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Cell Cycle—CCND1—brain cancer	0.000156	0.000254	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Immune System—IL2—brain cancer	0.000155	0.000252	CbGpPWpGaD
Ingenol Mebutate—PRKCA—GPCR downstream signaling—PIK3CG—brain cancer	0.000152	0.000248	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Disease—PDGFRA—brain cancer	0.000151	0.000245	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Immune System—CTNNB1—brain cancer	0.00015	0.000243	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Innate Immune System—CTNNB1—brain cancer	0.000147	0.00024	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Hemostasis—VEGFA—brain cancer	0.000144	0.000234	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Immune System—IRS2—brain cancer	0.000143	0.000233	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling Pathways—APC—brain cancer	0.000142	0.000231	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling Pathways—PIK3CG—brain cancer	0.000142	0.000231	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Cell Cycle, Mitotic—MYC—brain cancer	0.00014	0.000227	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by GPCR—PIK3CG—brain cancer	0.000138	0.000225	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Disease—CTNNB1—brain cancer	0.000138	0.000224	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—NOTCH2—brain cancer	0.000135	0.000219	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Disease—IRS2—brain cancer	0.000132	0.000215	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Immune System—STAT3—brain cancer	0.00013	0.000212	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling by GPCR—EGFR—brain cancer	0.00013	0.000211	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—VAV1—brain cancer	0.000129	0.000209	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Cell Cycle—MYC—brain cancer	0.000125	0.000203	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Gene Expression—MYC—brain cancer	0.00012	0.000196	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Disease—STAT3—brain cancer	0.00012	0.000195	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Immune System—EGFR—brain cancer	0.000118	0.000192	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Innate Immune System—EGFR—brain cancer	0.000117	0.00019	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Disease—APC—brain cancer	0.000117	0.00019	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Disease—MYC—brain cancer	0.000112	0.000182	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling Pathways—RELA—brain cancer	0.000111	0.000181	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—HES1—brain cancer	0.000111	0.00018	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling Pathways—ERBB2—brain cancer	0.000111	0.00018	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Disease—EGFR—brain cancer	0.000109	0.000178	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Hemostasis—TP53—brain cancer	0.000109	0.000177	CbGpPWpGaD
Ingenol Mebutate—PRKCA—GPCR downstream signaling—IL2—brain cancer	0.000107	0.000174	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—PDGFRA—brain cancer	0.000105	0.000171	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Cell Cycle—TP53—brain cancer	0.000103	0.000167	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—SPP1—brain cancer	0.000102	0.000166	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling Pathways—IL2—brain cancer	0.0001	0.000163	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Immune System—RELA—brain cancer	9.88e-05	0.00016	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Immune System—ERBB2—brain cancer	9.82e-05	0.000159	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Metabolism—PIK3CG—brain cancer	9.78e-05	0.000159	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling Pathways—CCND1—brain cancer	9.76e-05	0.000159	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by GPCR—IL2—brain cancer	9.74e-05	0.000158	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling Pathways—CTNNB1—brain cancer	9.67e-05	0.000157	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—IRS2—brain cancer	9.26e-05	0.00015	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Disease—ERBB2—brain cancer	9.06e-05	0.000147	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Immune System—IL2—brain cancer	8.9e-05	0.000145	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Immune System—CTNNB1—brain cancer	8.59e-05	0.00014	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling Pathways—VEGFA—brain cancer	8.51e-05	0.000138	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling Pathways—STAT3—brain cancer	8.43e-05	0.000137	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—APC—brain cancer	8.18e-05	0.000133	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—PIK3CG—brain cancer	8.18e-05	0.000133	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Disease—CTNNB1—brain cancer	7.93e-05	0.000129	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling Pathways—MYC—brain cancer	7.83e-05	0.000127	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling Pathways—EGFR—brain cancer	7.66e-05	0.000124	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Immune System—STAT3—brain cancer	7.49e-05	0.000122	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by GPCR—EGFR—brain cancer	7.45e-05	0.000121	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Gene Expression—MYC—brain cancer	6.92e-05	0.000112	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Disease—STAT3—brain cancer	6.91e-05	0.000112	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Immune System—EGFR—brain cancer	6.81e-05	0.000111	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling Pathways—TP53—brain cancer	6.43e-05	0.000104	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Disease—MYC—brain cancer	6.42e-05	0.000104	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—RELA—brain cancer	6.39e-05	0.000104	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—ERBB2—brain cancer	6.35e-05	0.000103	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Disease—EGFR—brain cancer	6.28e-05	0.000102	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—IL2—brain cancer	5.75e-05	9.34e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—CCND1—brain cancer	5.61e-05	9.11e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—CTNNB1—brain cancer	5.55e-05	9.02e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—VEGFA—brain cancer	4.89e-05	7.94e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—STAT3—brain cancer	4.84e-05	7.86e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—MYC—brain cancer	4.5e-05	7.31e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—EGFR—brain cancer	4.4e-05	7.15e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—TP53—brain cancer	3.69e-05	6e-05	CbGpPWpGaD
